Arizona Pulmonary Specialists, Ltd.

Scottsdale, Arizona 85258

2 studies enrolling now · 7 studies all time

What they study most

COPD, Healthy Volunteers, Pulmonary Arterial Hypertension, Idiopathic Pulmonary Fibrosis, Lung Diseases, Obstructive, Pulmonary Arterial Hypertension, Pulmonary Disease, Chronic Obstructive, Pulmonary Hypertension Due to Lung Disease (Disorder)

Studies at this site

• A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) — Recruiting now
• A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD — Recruiting now
• Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension — Running, not enrolling
• Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis — Completed
• Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early
• Long-Term Safety Study of GS-6624 in Adults With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early
• 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed